🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/08/2016 | 121,01 | 126,65 | 121,01 | 125,08 | +3,36% | 4,66% | 1.025.800 |
| 29/07/2016 | 118,97 | 122,23 | 118,19 | 121,01 | +1,70% | 3,40% | 868.800 |
| 28/07/2016 | 114,01 | 119,92 | 112,73 | 118,99 | +5,11% | 6,31% | 956.000 |
| 27/07/2016 | 112,52 | 114,12 | 111,19 | 113,20 | +0,67% | 2,60% | 526.300 |
| 26/07/2016 | 111,75 | 113,19 | 111,57 | 112,45 | +0,29% | 1,45% | 392.000 |
| 25/07/2016 | 111,65 | 112,50 | 110,72 | 112,13 | +0,65% | 1,59% | 414.900 |
| 22/07/2016 | 113,00 | 113,43 | 111,29 | 111,41 | -0,91% | 1,89% | 412.900 |
| 21/07/2016 | 115,25 | 115,87 | 111,83 | 112,43 | -2,09% | 3,51% | 540.100 |
| 20/07/2016 | 112,00 | 115,12 | 111,77 | 114,83 | +3,57% | 2,99% | 676.700 |
| 19/07/2016 | 111,07 | 112,03 | 109,71 | 110,87 | +0,01% | 2,09% | 454.200 |
| 18/07/2016 | 111,01 | 112,06 | 110,01 | 110,86 | +0,10% | 1,85% | 331.100 |
| 15/07/2016 | 111,00 | 112,55 | 110,25 | 110,75 | +0,49% | 2,07% | 431.300 |
| 14/07/2016 | 110,58 | 110,94 | 109,18 | 110,21 | +0,89% | 1,59% | 430.800 |
| 13/07/2016 | 113,44 | 113,44 | 108,40 | 109,24 | -3,27% | 4,44% | 621.000 |
| 12/07/2016 | 111,20 | 113,77 | 110,21 | 112,93 | +2,44% | 3,20% | 617.600 |
| 11/07/2016 | 112,06 | 112,06 | 108,50 | 110,24 | -0,83% | 3,18% | 507.100 |
| 08/07/2016 | 109,44 | 111,87 | 109,38 | 111,16 | +1,44% | 2,28% | 652.800 |
| 07/07/2016 | 110,63 | 111,89 | 108,83 | 109,58 | -0,54% | 2,77% | 468.100 |
| 06/07/2016 | 107,60 | 110,83 | 106,26 | 110,17 | +2,26% | 4,25% | 782.000 |
| 05/07/2016 | 109,06 | 109,86 | 106,46 | 107,73 | -1,07% | 3,12% | 624.300 |
| 01/07/2016 | 106,27 | 109,04 | 105,33 | 108,89 | +2,80% | 3,49% | 583.800 |
| 30/06/2016 | 103,76 | 106,09 | 103,30 | 105,92 | +2,30% | 2,69% | 657.400 |
| 29/06/2016 | 102,95 | 104,88 | 100,70 | 103,54 | +1,79% | 4,06% | 574.800 |
| 28/06/2016 | 99,25 | 102,00 | 98,61 | 101,72 | +3,45% | 3,42% | 571.700 |
| 27/06/2016 | 101,46 | 102,57 | 97,52 | 98,33 | -3,70% | 4,98% | 719.600 |
| 24/06/2016 | 101,28 | 104,93 | 101,10 | 102,11 | -3,01% | 3,78% | 1.343.000 |
| 23/06/2016 | 104,35 | 105,40 | 102,92 | 105,28 | +1,86% | 2,38% | 532.800 |
| 22/06/2016 | 102,61 | 106,36 | 102,33 | 103,36 | +1,53% | 3,93% | 625.100 |
| 21/06/2016 | 104,27 | 104,27 | 101,03 | 101,80 | -1,76% | 3,11% | 600.800 |
| 20/06/2016 | 103,84 | 105,00 | 102,63 | 103,62 | +1,48% | 2,28% | 581.300 |